J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
You may also be interested in...
Medtronic Gears For Stent Patent Infringement Showdowns With J&J, Guidant
Medtronic's Endeavor drug-eluting stent program and current coronary stent line-up are unaffected by a recent Johnson & Johnson patent infringement ruling against the company, Medtronic insists
Medtronic Gears For Stent Patent Infringement Showdowns With J&J, Guidant
Medtronic's Endeavor drug-eluting stent program and current coronary stent line-up are unaffected by a recent Johnson & Johnson patent infringement ruling against the company, Medtronic insists
J&J/Medtronic stent litigation
Medtronic will seek Supreme Court review after petition from both parties for rehearing - and rehearing en banc - of Palmaz stent patent suit is denied by U.S. Court of Appeals for the Federal Circuit Sept. 29. The court sided with J&J in August, and remanded the case back to its original Delaware district court (1"The Gray Sheet" Aug. 18, 2003, p. 4)...